Aijun Wang,Kurt Shanebeck,Donggou He,Chen Yao,Lu Li,Fang Xia,Yuefeng Lu,Jian-Feng Lu,Lan Yang
申请号：
US15620771
公开号：
US10077308B2
申请日:
2017.06.12
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The present invention relates to compositions and methods for immunotherapy of a subject afflicted with diseases such as cancer, an infectious disease, or a neurodegenerative disease, which methods comprise administering to the subject a composition comprising a therapeutically effective amount of an anti-PD-L1 antibody or portion thereof that potentiates an endogenous immune response, either stimulating the activation of the endogenous response or inhibiting the suppression of the endogenous response.
